Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nathaniel Weygant Yang Ge |
| Publication date | April 16, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |